Coagulation and inflammation

Journal of Endotoxin Research

Volumn 7, Issue 4, 2001, Pages 301-304

  Van der Poll, T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; THROMBOPLASTIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BABOON; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE SEVERITY; HOMEOSTASIS AND REGULATION; HUMAN; HUMAN EXPERIMENT; INFECTION; INFLAMMATION; NONHUMAN; NORMAL HUMAN; SEPSIS;

ANIMALS; BLOOD COAGULATION; HUMANS; INFECTION; INFLAMMATION;

ANIMALIA; PAPIO HAMADRYAS;

EID: 0034764270     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805101101532891     Document Type: Article

References (24)

1. Pathogenesis of DIC
2. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation
3. Tissue factor pathway inhibitor (TFPI) dose-dependently inhibits coagulation activation without influencing the fibrinolytic and the cytokine response during human endotoxemia
4. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
5. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
6. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli
7. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
8. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon Gram-negative model of septic shock
9. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage
10. Cytokines and anti-cytokines in the pathogenesis of sepsis
11. Activation of coagulation after administration of tumor necrosis factor to normal subjects
12. 2 in sepsis. Studies in non-human primates following interleukin-1a lethal bacteremia
13. Interleukin 12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees
14. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans
15. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
16. 100 septic shock following therapy with antibody to tumor necrosis factor (TNF)
17. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans
18. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
19. Interleukin 10 inhibits activation of coagulation and fibrinolysis during human endotoxemia
20. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia
21. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
22. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
23. Introduction: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
24. Efficacy and safety of recombinant human activated protein C for severe sepsis